vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Whitestone REIT（WSR）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Whitestone REIT的1.7倍（$75.5M vs $43.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 7.5%），Whitestone REIT自由现金流更多（$50.5M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 8.7%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Whitestone REIT是一家公开上市的房地产投资信托公司，主要收购、持有、管理及重新开发露天社区购物中心，资产多分布于美国西南部和东南部的高增长都市区，租户以满足本地居民日常需求的服务类零售商家为主。
PBYI vs WSR — 直观对比
营收规模更大
PBYI
是对方的1.7倍
$43.9M
营收增速更快
PBYI
高出20.2%
7.5%
自由现金流更多
WSR
多$36.1M
$14.4M
两年增速更快
PBYI
近两年复合增速
8.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $43.9M |
| 净利润 | — | $22.8M |
| 毛利率 | 69.3% | — |
| 营业利润率 | 22.7% | 53.0% |
| 净利率 | — | 52.0% |
| 营收同比 | 27.7% | 7.5% |
| 净利润同比 | — | 31.7% |
| 每股收益（稀释后） | $0.26 | $0.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIWSR
| Q4 25 | $75.5M | $43.9M | ||
| Q3 25 | $54.5M | $41.0M | ||
| Q2 25 | $52.4M | $37.9M | ||
| Q1 25 | $46.0M | $38.0M | ||
| Q4 24 | $59.1M | $40.8M | ||
| Q3 24 | $80.5M | $38.6M | ||
| Q2 24 | $47.1M | $37.6M | ||
| Q1 24 | $43.8M | $37.2M |
净利润PBYIWSR
| Q4 25 | — | $22.8M | ||
| Q3 25 | $8.8M | $18.3M | ||
| Q2 25 | $5.9M | $5.1M | ||
| Q1 25 | $3.0M | $3.7M | ||
| Q4 24 | — | $17.3M | ||
| Q3 24 | $20.3M | $7.6M | ||
| Q2 24 | $-4.5M | $2.6M | ||
| Q1 24 | $-4.8M | $9.3M |
毛利率PBYIWSR
| Q4 25 | 69.3% | — | ||
| Q3 25 | 77.7% | — | ||
| Q2 25 | 76.5% | — | ||
| Q1 25 | 77.1% | — | ||
| Q4 24 | 76.4% | — | ||
| Q3 24 | 63.9% | — | ||
| Q2 24 | 77.4% | — | ||
| Q1 24 | 75.5% | — |
营业利润率PBYIWSR
| Q4 25 | 22.7% | 53.0% | ||
| Q3 25 | 17.6% | 45.5% | ||
| Q2 25 | 12.7% | 13.8% | ||
| Q1 25 | 8.7% | 10.2% | ||
| Q4 24 | 22.6% | 43.3% | ||
| Q3 24 | 27.4% | 20.3% | ||
| Q2 24 | -4.6% | 7.2% | ||
| Q1 24 | -5.3% | 25.9% |
净利率PBYIWSR
| Q4 25 | — | 52.0% | ||
| Q3 25 | 16.2% | 44.7% | ||
| Q2 25 | 11.2% | 13.3% | ||
| Q1 25 | 6.5% | 9.7% | ||
| Q4 24 | — | 42.5% | ||
| Q3 24 | 25.2% | 19.7% | ||
| Q2 24 | -9.6% | 6.9% | ||
| Q1 24 | -11.0% | 25.1% |
每股收益（稀释后）PBYIWSR
| Q4 25 | $0.26 | $0.43 | ||
| Q3 25 | $0.17 | $0.35 | ||
| Q2 25 | $0.12 | $0.10 | ||
| Q1 25 | $0.06 | $0.07 | ||
| Q4 24 | $0.40 | $0.34 | ||
| Q3 24 | $0.41 | $0.15 | ||
| Q2 24 | $-0.09 | $0.05 | ||
| Q1 24 | $-0.10 | $0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $4.9M |
| 总债务越低越好 | $22.7M | $649.4M |
| 股东权益账面价值 | $130.3M | $458.1M |
| 总资产 | $216.3M | $1.2B |
| 负债/权益比越低杠杆越低 | 0.17× | 1.42× |
8季度趋势，按日历期对齐
现金及短期投资PBYIWSR
| Q4 25 | $97.5M | $4.9M | ||
| Q3 25 | $94.4M | $6.8M | ||
| Q2 25 | $96.0M | $5.3M | ||
| Q1 25 | $93.2M | $5.6M | ||
| Q4 24 | $101.0M | $5.2M | ||
| Q3 24 | $96.7M | $2.5M | ||
| Q2 24 | $96.8M | $3.2M | ||
| Q1 24 | $107.2M | $6.2M |
总债务PBYIWSR
| Q4 25 | $22.7M | $649.4M | ||
| Q3 25 | $34.0M | — | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | — | ||
| Q4 24 | $68.0M | $632.5M | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIWSR
| Q4 25 | $130.3M | $458.1M | ||
| Q3 25 | $115.3M | $439.5M | ||
| Q2 25 | $104.7M | $427.5M | ||
| Q1 25 | $97.1M | $431.0M | ||
| Q4 24 | $92.1M | $438.2M | ||
| Q3 24 | $71.1M | $419.5M | ||
| Q2 24 | $48.5M | $418.3M | ||
| Q1 24 | $51.0M | $421.6M |
总资产PBYIWSR
| Q4 25 | $216.3M | $1.2B | ||
| Q3 25 | $202.9M | $1.1B | ||
| Q2 25 | $194.9M | $1.2B | ||
| Q1 25 | $196.2M | $1.1B | ||
| Q4 24 | $213.3M | $1.1B | ||
| Q3 24 | $220.7M | $1.1B | ||
| Q2 24 | $205.0M | $1.1B | ||
| Q1 24 | $214.1M | $1.1B |
负债/权益比PBYIWSR
| Q4 25 | 0.17× | 1.42× | ||
| Q3 25 | 0.30× | — | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.74× | 1.44× | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $50.8M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $50.5M |
| 自由现金流率自由现金流/营收 | 19.1% | 114.9% |
| 资本支出强度资本支出/营收 | 0.0% | 0.7% |
| 现金转化率经营现金流/净利润 | — | 2.22× |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYIWSR
| Q4 25 | $14.4M | $50.8M | ||
| Q3 25 | $9.7M | $18.0M | ||
| Q2 25 | $14.1M | $13.8M | ||
| Q1 25 | $3.6M | $3.1M | ||
| Q4 24 | $15.6M | $58.2M | ||
| Q3 24 | $11.0M | $16.4M | ||
| Q2 24 | $1.0M | $12.3M | ||
| Q1 24 | $11.2M | $11.5M |
自由现金流PBYIWSR
| Q4 25 | $14.4M | $50.5M | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | — | ||
| Q4 24 | $15.6M | $58.0M | ||
| Q3 24 | $11.0M | — | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYIWSR
| Q4 25 | 19.1% | 114.9% | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | — | ||
| Q4 24 | 26.4% | 142.1% | ||
| Q3 24 | 13.7% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYIWSR
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.0% | — |
现金转化率PBYIWSR
| Q4 25 | — | 2.22× | ||
| Q3 25 | 1.10× | 0.98× | ||
| Q2 25 | 2.41× | 2.74× | ||
| Q1 25 | 1.21× | 0.83× | ||
| Q4 24 | — | 3.36× | ||
| Q3 24 | 0.54× | 2.15× | ||
| Q2 24 | — | 4.73× | ||
| Q1 24 | — | 1.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
